Study Site — Washington D.C., District of Columbia

Study Site is a clinical research site located in Washington D.C., District of Columbia, United States.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Study Site has participated in 4 clinical trials.

Therapeutic areas: Sickle Cell Disease, Sickle Cell Anemia, Schizophrenia.

Sponsors: Icagen, Otsuka Pharmaceutical Development & Commercialization, Inc., GlaxoSmithKline.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site?

Study Site has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site conducted?

Study Site has 4 clinical trials on record. Their work covers Sickle Cell Disease, Sickle Cell Anemia, Schizophrenia.

Is Study Site accredited by Crixeo Health?

Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.